No­vo Hold­ings in­vests in Hemab, a com­pa­ny go­ing against the he­mo­phil­ia gene ther­a­py grain with a plan for bis­pecifics

No­vo Hold­ings, the hold­ing com­pa­ny com­pris­ing No­vo Nordisk and man­ag­ing the No­vo Nordisk Foun­da­tion’s as­sets, has made a new in­vest­ment through its seed cap­i­tal arm …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER